COVID-19 has affected a large amount of people disturbing the lives of people be it health, business, daily chores, schooling of students and education. Many countries are on the way to make the vaccine but no vaccine is still ready to be passed to the people who are victim of the dangerous COVID-19. When a disease is new, the treatment takes time to be made, the vaccine is under progress in making for the coronavirus vaccine. Everyone is in the race of making the first vaccine. From USA to Iran to India everyone is trying their best with the best scientists, researchers and doctors.
Out of 110+ research groups, more than three groups are proceeding onto phase III clinical trials, which is considered to be the most critical and important one. Some leading competitors in the race are Oxford-Astrazeneca, CanSino BioTech and Moderna Inc, who are planning to conduct large scale trials in different countries. Apart from this, Imperial College of London, another vaccine group has started dosing patients with their novel vaccine in phase I. It is expected that we would have a vaccine ready by December 2020, but a lot more research is pending before we reach that stage.A low-cost steroid drug, commonly used to treat inflammation, Dexamethason emerged as the biggest saviour for patients suffering from critical symptoms of COVID-19 after it was observed that the medicine was able to cut down mortality rates in patients put on ventilator support, as well as by 1/5th in those hospitalized with other acute symptoms. The research has been backed by experts from the University of Oxford, who even suggested using the drug in hospitals across the world. While more studies are underway, researchers are very sure about the drug’s safety and working.
Pharmaceutical giant, Genmark won the approval to supply the antiviral medicine in the form of Fabiflu for COVID-19 treatment in the country, which is seeing a surge in cases every day. The company has also claimed that the medicine can be extremely effecting in treating positive patients who suffer from co-morbidities, such as diabetes and high blood pressure. The firm has fixed its price at Rs 103 per tablet.Remdesivir is another promising drug being used as an experimental drug to fight the novel coronavirus outbreak. Preliminary trials have shown that patients who were prescribed the direct-acting antiviral drug tend to recover faster than those who were given a placebo drug. However, since it again is an experimental drug, the results cannot be collated unless large scale studies are done.
Patanjali Ayurved’s Coronil, hailed by the makers as the first “100% cure” for COVID-19 ran into troubled waters after ICMR and Ministry of Ayush asked them to halt its promotion and surface studies of clinical trials first. Even as research regarding the same is still underway, the makers have assured that the ayurvedic formulation guarantees effective results, has a good recovery rate and trials have proven the same. Acharya Balkrishna also claimed that their potent drug, made out of Ayurvedic herbs such as Giloy and Ashwagandha were able to decrease the viral load in the body.
Let’s see who will win the race by finding the cure for Coronavirus. Whosoever finds but it will be very helpful for the world and people would soon recover.
Eduindex News 